QUE: QUE Oncology launches phase 2 trials in the US
QUE Oncology is developing drugs for large unmet medical needs and has already advanced clinical development of its lead drug program Q122 through four Phase 1 trials. QUE The post QUE Oncology launches phase 2 trials in the US appeared first on Pharmaceut...
Read full article »
QUE Oncology focuses on developing and commercializing novel therapies for the treatment of cancer.
Read more